Markets

Thursday 11/6 Insider Buying Report: BIOL, ELGX

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.

At Biolase ( BIOL ), a filing with the SEC revealed that on Monday, Director Paul N. Clark purchased 404,653 shares of BIOL, at a cost of $2.39 each, for a total investment of $967,121. Biolase is trading down about 1.2% on the day Thursday. Before this latest buy, Clark made one other purchase in the past twelve months, buying $999,999 shares at a cost of $1.92 a piece.

And on Tuesday, Chief Executive Officer John D. McDermott bought $281,250 worth of Endologix ( ELGX ), buying 25,000 shares at a cost of $11.25 a piece. Endologix is trading up about 0.3% on the day Thursday. McDermott was up about 1.2% on the buy at the high point of today's trading session, with ELGX trading as high as $11.39 at last check today.

VIDEO: Thursday 11/6 Insider Buying Report: BIOL, ELGX

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

BIOL

Other Topics

Investing

Latest Markets Videos

    BNK Invest

    BNK Invest Inc. provides investment services and information. BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and others, which make up an investor community featuring stock message boards, ratings, research, and strategies. BNK Invest caters to investing firms and individual investors internationally.

    Learn More